News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,777 Results
Type
Article (43421)
Company Profile (356)
Press Release (672000)
Section
Business (211585)
Career Advice (2083)
Deals (36346)
Drug Delivery (94)
Drug Development (82088)
Employer Resources (172)
FDA (16650)
Job Trends (15270)
News (355576)
Policy (33325)
Tag
Academia (2683)
Alliances (52179)
Alzheimer's disease (1272)
Approvals (16583)
Artificial intelligence (164)
Bankruptcy (357)
Best Places to Work (11863)
Biotechnology (253)
Breast cancer (189)
Cancer (1345)
Cardiovascular disease (107)
Career advice (1742)
Cell therapy (283)
Clinical research (65373)
Collaboration (463)
Compensation (248)
COVID-19 (2625)
C-suite (112)
Data (1379)
Diabetes (164)
Diagnostics (6433)
Earnings (86474)
Employer resources (151)
Events (114586)
Executive appointments (375)
FDA (17293)
Funding (426)
Gene therapy (202)
GLP-1 (608)
Government (4433)
Healthcare (19400)
Infectious disease (2716)
Inflammatory bowel disease (113)
Interviews (320)
IPO (16670)
Job creations (3814)
Job search strategy (1489)
Layoffs (429)
Legal (8078)
Lung cancer (189)
Manufacturing (198)
Medical device (13933)
Medtech (13938)
Mergers & acquisitions (19812)
Metabolic disorders (439)
Neuroscience (1588)
NextGen Class of 2024 (6832)
Non-profit (4603)
Northern California (1659)
Obesity (252)
Opinion (192)
Patents (120)
People (58605)
Phase I (20482)
Phase II (28765)
Phase III (21368)
Pipeline (506)
Postmarket research (2579)
Preclinical (8796)
Radiopharmaceuticals (254)
Rare diseases (258)
Real estate (6216)
Regulatory (22198)
Research institute (2448)
Resumes & cover letters (361)
Southern California (1446)
Startups (3827)
United States (15132)
Vaccines (590)
Weight loss (180)
Date
Last 7 days (692)
Last 30 days (2499)
Last 365 days (36240)
2024 (35416)
2023 (41136)
2022 (52397)
2021 (56996)
2020 (55616)
2019 (48410)
2018 (36442)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (754)
Arizona (203)
Asia (39885)
Australia (6627)
California (3758)
Canada (1417)
China (297)
Colorado (173)
Connecticut (176)
Europe (87105)
Florida (517)
Georgia (138)
Illinois (392)
Indiana (224)
Kansas (99)
Maryland (627)
Massachusetts (2970)
Michigan (185)
Minnesota (294)
New Jersey (1084)
New York (1059)
North Carolina (774)
Northern California (1659)
Ohio (146)
Pennsylvania (912)
South America (1149)
Southern California (1446)
Texas (541)
Utah (110)
Washington State (403)
715,777 Results for "transomic technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
IMUNON Announces Strategic Investment in Transomic Technologies
IMUNON, Inc. announced a $375,000 investment in Transomic Technologies, a private company offering a comprehensive array of CRISPR, RNAi and gene expression tools and services.
November 17, 2022
·
6 min read
Bio NC
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
G1 Therapeutics, Inc., a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement for lerociclib for all indications except for certain radioprotectant uses.
May 1, 2024
·
7 min read
Pharm Country
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference 2024
Helius Medical Technologies, Inc. announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC.
May 31, 2024
·
6 min read
News
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 18, 2024
·
1 min read
Business
GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.
June 20, 2024
·
2 min read
Press Releases
Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG
November 1, 2024
·
11 min read
Lone Star Bio
Retractable Technologies, Inc. Reports Results for 2023
Retractable Technologies, Inc. reports the following information relating to the year ended December 31, 2023.
March 29, 2024
·
4 min read
Press Releases
Heart Repair Technologies, Inc. Appoints David H. Chung as Chief Executive Officer
October 28, 2024
·
3 min read
Pharm Country
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. announced the completion of site participation enrollment for its stroke registrational program in the U.S. with the addition of REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions.
June 17, 2024
·
10 min read
Business
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended March 31, 2024.
May 13, 2024
·
10 min read
1 of 71,578
Next
